Provided by Tiger Trade Technology Pte. Ltd.

Atrium Therapeutics

14.75
-0.0310-0.21%
Post-market: 14.08-0.6700-4.54%19:59 EST
Volume:7.96M
Turnover:123.59M
Market Cap:2.28B
PE:- -
High:15.93
Open:14.58
Low:13.06
Close:14.78
52wk High:73.06
52wk Low:13.06
Shares:154.74M
Float Shares:132.00M
Volume Ratio:1.25
T/O Rate:6.03%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-4.9715
ROE:-43.98%
ROA:-26.47%
PB:1.35
PE(LYR):-2.97

Loading ...

Feb 23, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 11, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 30, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 27, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 21, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Dec 16, 2022

Major Issues Report

8-K - Current report
Dec 14, 2022

Major Issues Report

8-K - Current report
Dec 05, 2022

Major Issues Report

8-K - Current report
Nov 08, 2022

Major Issues Report

8-K - Current report
Nov 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 13, 2022

Major Issues Report

8-K - Current report
Oct 04, 2022

Major Issues Report

8-K - Current report
Sep 27, 2022

Major Issues Report

8-K - Current report
Aug 18, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 09, 2022

Major Issues Report

8-K - Current report
Aug 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 17, 2022

Major Issues Report

8-K - Current report